Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

Also called NCT06406517

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose other
Phase
Phase 3
Enrolled
  • 161 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06406517
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06406517. Randomized; triple masking; primary purpose other. Start 2024-08-05 (actual); primary completion 2026-04-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics
Condition
Congenital Heart Disease
Intervention (Drug)
Gadopiclenol
Intervention (Drug)
Gadobenate dimeglumine
Lead sponsor
University of California, San Diego (class: other)
Collaborator
Bracco Imaging S.p.A. (class: industry)

Record details

Record id
cardio:ct-nct06406517
Content hash
cbe39713c8464b7b285692c97e03212caf2355302dc2fae22c8fa16d41cbf5a5